Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy.
Identifieur interne : 004028 ( PubMed/Curation ); précédent : 004027; suivant : 004029Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy.
Auteurs : Pauline T. Truong ; Ivo A. Olivotto ; Timothy J. Whelan ; Mark LevineSource :
- CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [ 0820-3946 ] ; 2004.
Descripteurs français
- KwdFr :
- MESH :
- effets indésirables : Radiothérapie.
- radiothérapie : Tumeurs du sein.
- Association thérapeutique, Femelle, Humains, Mastectomie, Médecine factuelle, Radiothérapie, Tumeurs du sein.
English descriptors
- KwdEn :
- MESH :
- adverse effects : Radiotherapy.
- methods : Radiotherapy.
- radiotherapy : Breast Neoplasms.
- surgery : Breast Neoplasms.
- Combined Modality Therapy, Evidence-Based Medicine, Female, Humans, Mastectomy.
Abstract
To provide information and recommendations to assist women with breast cancer and their physicians in making decisions regarding the use of locoregional post-mastectomy radiotherapy (PMRT).
PubMed: 15078851
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004028
Links to Exploration step
pubmed:15078851Curation
No country items
Pauline T. Truong<affiliation><nlm:affiliation>BC Cancer Agency-Vancouver Island Centre.</nlm:affiliation>
<wicri:noCountry code="no comma">BC Cancer Agency-Vancouver Island Centre.</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy.</title>
<author><name sortKey="Truong, Pauline T" sort="Truong, Pauline T" uniqKey="Truong P" first="Pauline T" last="Truong">Pauline T. Truong</name>
<affiliation><nlm:affiliation>BC Cancer Agency-Vancouver Island Centre.</nlm:affiliation>
<wicri:noCountry code="no comma">BC Cancer Agency-Vancouver Island Centre.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Olivotto, Ivo A" sort="Olivotto, Ivo A" uniqKey="Olivotto I" first="Ivo A" last="Olivotto">Ivo A. Olivotto</name>
</author>
<author><name sortKey="Whelan, Timothy J" sort="Whelan, Timothy J" uniqKey="Whelan T" first="Timothy J" last="Whelan">Timothy J. Whelan</name>
</author>
<author><name sortKey="Levine, Mark" sort="Levine, Mark" uniqKey="Levine M" first="Mark" last="Levine">Mark Levine</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15078851</idno>
<idno type="pmid">15078851</idno>
<idno type="wicri:Area/PubMed/Corpus">004028</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004028</idno>
<idno type="wicri:Area/PubMed/Curation">004028</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004028</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy.</title>
<author><name sortKey="Truong, Pauline T" sort="Truong, Pauline T" uniqKey="Truong P" first="Pauline T" last="Truong">Pauline T. Truong</name>
<affiliation><nlm:affiliation>BC Cancer Agency-Vancouver Island Centre.</nlm:affiliation>
<wicri:noCountry code="no comma">BC Cancer Agency-Vancouver Island Centre.</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Olivotto, Ivo A" sort="Olivotto, Ivo A" uniqKey="Olivotto I" first="Ivo A" last="Olivotto">Ivo A. Olivotto</name>
</author>
<author><name sortKey="Whelan, Timothy J" sort="Whelan, Timothy J" uniqKey="Whelan T" first="Timothy J" last="Whelan">Timothy J. Whelan</name>
</author>
<author><name sortKey="Levine, Mark" sort="Levine, Mark" uniqKey="Levine M" first="Mark" last="Levine">Mark Levine</name>
</author>
</analytic>
<series><title level="j">CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</title>
<idno type="ISSN">0820-3946</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast Neoplasms (radiotherapy)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Combined Modality Therapy</term>
<term>Evidence-Based Medicine</term>
<term>Female</term>
<term>Humans</term>
<term>Mastectomy</term>
<term>Radiotherapy (adverse effects)</term>
<term>Radiotherapy (methods)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Association thérapeutique</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mastectomie</term>
<term>Médecine factuelle</term>
<term>Radiothérapie ()</term>
<term>Radiothérapie (effets indésirables)</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (radiothérapie)</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Radiotherapy</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Radiothérapie</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Radiotherapy</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Combined Modality Therapy</term>
<term>Evidence-Based Medicine</term>
<term>Female</term>
<term>Humans</term>
<term>Mastectomy</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Association thérapeutique</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mastectomie</term>
<term>Médecine factuelle</term>
<term>Radiothérapie</term>
<term>Tumeurs du sein</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To provide information and recommendations to assist women with breast cancer and their physicians in making decisions regarding the use of locoregional post-mastectomy radiotherapy (PMRT).</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15078851</PMID>
<DateCreated><Year>2004</Year>
<Month>04</Month>
<Day>13</Day>
</DateCreated>
<DateCompleted><Year>2004</Year>
<Month>06</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>06</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0820-3946</ISSN>
<JournalIssue CitedMedium="Print"><Volume>170</Volume>
<Issue>8</Issue>
<PubDate><Year>2004</Year>
<Month>Apr</Month>
<Day>13</Day>
</PubDate>
</JournalIssue>
<Title>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</Title>
<ISOAbbreviation>CMAJ</ISOAbbreviation>
</Journal>
<ArticleTitle>Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy.</ArticleTitle>
<Pagination><MedlinePgn>1263-73</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To provide information and recommendations to assist women with breast cancer and their physicians in making decisions regarding the use of locoregional post-mastectomy radiotherapy (PMRT).</AbstractText>
<AbstractText Label="OUTCOMES" NlmCategory="RESULTS">Locoregional control, disease-free survival, overall survival and treatment-related toxicities.</AbstractText>
<AbstractText Label="EVIDENCE" NlmCategory="METHODS">This guideline is based on a review of all meta-analyses, consensus statements and other guidelines published between 1966 and November 2002. Searches of MEDLINE and CANCERLIT for English-language randomized controlled trials published between 1995 and November 2002 were also conducted to supplement the literature previously reviewed by the American Society of Clinical Oncology (ASCO) Health Services Research Committee panel in its published guideline. A nonsystematic review of the literature was continued through June 2003.</AbstractText>
<AbstractText Label="RECOMMENDATIONS" NlmCategory="CONCLUSIONS">Locoregional PMRT is recommended for women with an advanced primary tumour (tumour size 5 cm or greater, or tumour invasion of the skin, pectoral muscle or chest wall). Locoregional PMRT is recommended for women with 4 or more positive axillary lymph nodes. The role of PMRT in women with 1 to 3 positive axillary lymph nodes is unclear. These women should be offered the opportunity to participate in clinical trials of PMRT. Locoregional PMRT is generally not recommended for women who have tumours that are less than 5 cm in diameter and who have negative axillary nodes. Other patient, tumour and treatment characteristics, including age, histologic grade, lymphovascular invasion, hormone receptor status, number of axillary nodes removed, axillary extracapsular extension and surgical margin status, may affect locoregional control, but their use in specifying additional indications for PMRT is currently unclear. PMRT should encompass the chest wall and the supraclavicular, infraclavicular and axillary apical lymph node areas. To reduce the risk of lymphedema, radiation of the entire axilla should not be used routinely after complete axillary dissection of level I and II lymph nodes. A definite recommendation regarding the inclusion of the internal mammary lymph nodes in PMRT cannot be made because of limited and inconsistent data. The use of modern techniques in radiotherapy planning is recommended to minimize excessive normal tissue exposure, particularly to the cardiac and pulmonary structures. Common short-term side effects of PMRT, including fatigue and skin erythema, are generally tolerable and not dose-limiting. Severe long-term side effects, including lymphedema, cardiac and pulmonary toxicities, brachial plexopathy, rib fractures and secondary neoplasms, are relatively rare. The optimal sequencing of PMRT and systemic therapy is currently unclear. Regimens containing anthracyclines or taxanes should not be administered concurrently with radiotherapy because of the potential for increased toxicity.</AbstractText>
<AbstractText Label="VALIDATION" NlmCategory="RESULTS">The authors' original text was submitted for review, revision and approval by the Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Subsequently, feedback was provided by 11 oncologists from across Canada. The final document was approved by the steering committee.</AbstractText>
<AbstractText Label="SPONSOR" NlmCategory="BACKGROUND">The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer was convened by Health Canada. COMPLETION DATE: November 2003.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Truong</LastName>
<ForeName>Pauline T</ForeName>
<Initials>PT</Initials>
<AffiliationInfo><Affiliation>BC Cancer Agency-Vancouver Island Centre.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Olivotto</LastName>
<ForeName>Ivo A</ForeName>
<Initials>IA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Whelan</LastName>
<ForeName>Timothy J</ForeName>
<Initials>TJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>Levine</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><CollectiveName>Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016431">Guideline</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017065">Practice Guideline</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Canada</Country>
<MedlineTA>CMAJ</MedlineTA>
<NlmUniqueID>9711805</NlmUniqueID>
<ISSNLinking>0820-3946</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1991 Jul;21(2):299-310</RefSource>
<PMID Version="1">2061107</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1991 Jul;21(2):355-60</RefSource>
<PMID Version="1">2061112</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 1991 Oct;19(2):77-84</RefSource>
<PMID Version="1">1756271</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 1992 Jan 4;339(8784):1-15</RefSource>
<PMID Version="1">1345950</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1992 Mar 19;326(12):781-5</RefSource>
<PMID Version="1">1538720</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1992;22(5):887-96</RefSource>
<PMID Version="1">1555981</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1992 Jun 25;326(26):1745-51</RefSource>
<PMID Version="1">1594016</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 1992;31(2):271-4</RefSource>
<PMID Version="1">1622645</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1992;23(5):915-23</RefSource>
<PMID Version="1">1639653</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 1992;28A(8-9):1415-8</RefSource>
<PMID Version="1">1515262</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 1992;28A(11):1833-7</RefSource>
<PMID Version="1">1389521</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 1992 Dec;66(6):1171-6</RefSource>
<PMID Version="1">1457360</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Surg Oncol. 1993 Jan;52(1):26-30</RefSource>
<PMID Version="1">8441257</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1993 Apr 30;26(1):43-9</RefSource>
<PMID Version="1">8387067</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1993 Aug 1;72(3):778-82</RefSource>
<PMID Version="1">8334631</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1993 Aug 15;72(4):1247-60</RefSource>
<PMID Version="1">8339215</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 1993;32(6):641-6</RefSource>
<PMID Version="1">8260183</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1994 Mar;12(3):447-53</RefSource>
<PMID Version="1">8120544</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Surg. 1994 Mar;81(3):386-9</RefSource>
<PMID Version="1">8173907</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1994 Jul 1;29(4):903-9</RefSource>
<PMID Version="1">8040041</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1995 Jan;13(1):47-53</RefSource>
<PMID Version="1">7799041</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):253-9</RefSource>
<PMID Version="1">7673012</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1995 Nov 30;333(22):1444-55</RefSource>
<PMID Version="1">7477144</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 1995 Sep;36(3):172-6</RefSource>
<PMID Version="1">8532902</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1996 May 23;334(21):1356-61</RefSource>
<PMID Version="1">8614420</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1996 Jul 3;88(13):918-22</RefSource>
<PMID Version="1">8656444</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2001 Jul 4;93(13):979-89</RefSource>
<PMID Version="1">11438563</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2001 Jul 1;92(1):172-80</RefSource>
<PMID Version="1">11443624</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2001 Dec 5;93(23):1806-11</RefSource>
<PMID Version="1">11734597</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst Monogr. 2001;(30):117-24</RefSource>
<PMID Version="1">11773304</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):137-43</RefSource>
<PMID Version="1">11777631</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2002 Feb 15;20(4):1036-42</RefSource>
<PMID Version="1">11844827</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 2002 Feb;62(2):163-71</RefSource>
<PMID Version="1">11937243</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1220-30</RefSource>
<PMID Version="1">11955732</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2002 May;38(8):1107-10</RefSource>
<PMID Version="1">12008199</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast J. 2002 May-Jun;8(3):149-53</RefSource>
<PMID Version="1">12047471</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2002 Aug 22;347(8):567-75</RefSource>
<PMID Version="1">12192016</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 2002 Aug;64(2):171-5</RefSource>
<PMID Version="1">12242127</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2002 Oct 15;20(20):4242-8</RefSource>
<PMID Version="1">12377968</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1997 Mar 15;79(6):1138-49</RefSource>
<PMID Version="1">9070491</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):551-9</RefSource>
<PMID Version="1">9231679</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1997 Oct 2;337(14):949-55</RefSource>
<PMID Version="1">9395428</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1997 Oct 2;337(14):956-62</RefSource>
<PMID Version="1">9309100</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1997 Oct 2;337(14):996-7</RefSource>
<PMID Version="1">9309106</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>CMAJ. 1998 Feb 10;158 Suppl 3:S1-2</RefSource>
<PMID Version="1">9484271</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>CMAJ. 1998 Feb 10;158 Suppl 3:S22-6</RefSource>
<PMID Version="1">9484275</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1998 Apr;16(4):1374-9</RefSource>
<PMID Version="1">9552040</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 1998 May 16;351(9114):1451-67</RefSource>
<PMID Version="1">9605801</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):599-605</RefSource>
<PMID Version="1">9635708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1998 Aug;16(8):2625-31</RefSource>
<PMID Version="1">9704712</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1998 Aug;16(8):2886-9</RefSource>
<PMID Version="1">9704743</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 1998 Aug;48(2):185-90</RefSource>
<PMID Version="1">9783890</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 1999 Oct 23;354(9188):1425-30</RefSource>
<PMID Version="1">10543669</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1999 Jun;17(6):1689-700</RefSource>
<PMID Version="1">10561205</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 1999 Sep;35(9):1320-5</RefSource>
<PMID Version="1">10658521</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2000 Mar;18(6):1220-9</RefSource>
<PMID Version="1">10715291</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2000 May 1;86(3):408-15</RefSource>
<PMID Version="1">10760830</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2000 May 20;355(9217):1757-70</RefSource>
<PMID Version="1">10832826</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2000 Aug;18(15):2817-27</RefSource>
<PMID Version="1">10920129</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2000;39(3):355-72</RefSource>
<PMID Version="1">10987233</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Radiology. 2000 Jun;215 Suppl:1153-70</RefSource>
<PMID Version="1">11037539</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2001 Jan 1;19(1):37-43</RefSource>
<PMID Version="1">11134193</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2001 Mar 1;19(5):1539-69</RefSource>
<PMID Version="1">11230499</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>CMAJ. 2001 Mar 6;164(5):644-6</RefSource>
<PMID Version="1">11258212</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>CMAJ. 2001 Jan 23;164(2):191-9</RefSource>
<PMID Version="1">11332311</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):735-42</RefSource>
<PMID Version="1">11395242</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1998 Nov;16(11):3493-501</RefSource>
<PMID Version="1">9817266</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Semin Radiat Oncol. 1999 Apr;9(2 Suppl 1):34-42</RefSource>
<PMID Version="1">10210538</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 1999 May 15;353(9165):1641-8</RefSource>
<PMID Version="1">10335782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):989-90</RefSource>
<PMID Version="1">10421530</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):69-72</RefSource>
<PMID Version="1">10477008</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1999 Oct 1;86(7):1258-62</RefSource>
<PMID Version="1">10506712</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1990 Oct;19(4):851-8</RefSource>
<PMID Version="1">2211253</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>CMAJ. 2003 Feb 18;168(4):437-9</RefSource>
<PMID Version="1">12591786</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2003 Apr 1;21(7):1195-204</RefSource>
<PMID Version="1">12663705</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2003 Apr 1;21(7):1205-13</RefSource>
<PMID Version="1">12663706</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Roentgenol Radium Ther Nucl Med. 1971 Jan;111(1):130-6</RefSource>
<PMID Version="1">5540919</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1976 Jan;37(1):206-14</RefSource>
<PMID Version="1">1247957</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Radiol Oncol Radiat Phys Biol. 1979;18(4):273-81</RefSource>
<PMID Version="1">525444</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1981 Jun 15;47(12):2833-9</RefSource>
<PMID Version="1">7020917</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Clin Oncol. 1982 Aug;5(4):371-81</RefSource>
<PMID Version="1">7051805</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1983 May 15;51(10):1941-3</RefSource>
<PMID Version="1">6339026</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1984 Aug 15;54(4):670-4</RefSource>
<PMID Version="1">6744203</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1985 Mar 14;312(11):674-81</RefSource>
<PMID Version="1">3883168</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 1985 Dec;202(6):702-7</RefSource>
<PMID Version="1">3000303</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Surg. 1986 Apr;73(4):264-6</RefSource>
<PMID Version="1">3697654</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Surg. 1986 Jul;73(7):580-4</RefSource>
<PMID Version="1">3730795</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1986 Sep;12(9):1575-82</RefSource>
<PMID Version="1">3759582</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Surg Gynecol Obstet. 1986 Dec;163(6):513-7</RefSource>
<PMID Version="1">3024341</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rep. 1987 Jan;71(1):15-29</RefSource>
<PMID Version="1">2856861</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1987 Sep 1;60(5):936-42</RefSource>
<PMID Version="1">3300953</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1987 Oct;5(10):1546-55</RefSource>
<PMID Version="1">3309196</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Surg Gynecol Obstet. 1988 Jun;166(6):523-6</RefSource>
<PMID Version="1">3375963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 1988;27(6A):699-705</RefSource>
<PMID Version="1">3064775</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Chest. 1989 Feb;95(2 Suppl):2S-4S</RefSource>
<PMID Version="1">2914516</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1989 Oct;17(4):703-10</RefSource>
<PMID Version="1">2550398</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 1990 Jul;18(3):213-20</RefSource>
<PMID Version="1">2217869</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1991 Jun;9(6):988-96</RefSource>
<PMID Version="1">2033433</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn"><RefSource>CMAJ. 2005 Jan 4;172(1):18; author reply 19</RefSource>
<PMID Version="1">15632391</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008408" MajorTopicYN="N">Mastectomy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011878" MajorTopicYN="N">Radiotherapy</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC385392</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>4</Month>
<Day>14</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2004</Year>
<Month>6</Month>
<Day>4</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>4</Month>
<Day>14</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15078851</ArticleId>
<ArticleId IdType="pmc">PMC385392</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004028 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 004028 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:15078851 |texte= Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:15078851" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |